MeSH Browser

MeSH Heading: Piperacillin, Tazobactam Drug Combination
Tree Number(s): D02.065.589.099.750.687.750.500; D02.065.589.099.750.750.050.650.500; D02.886.108.750.687.750.500; D02.886.108.750.750.050.650.500; D02.886.590.841.500; D03.633.100.300.750.687.750.500; D03.633.100.300.750.750.050.650.500; D26.310.625
Unique ID: D000077725
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000077725
Scope Note: An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS.
Entry Term(s): Piperacillin - Tazobactam; Piperacillin-Tazobactam Combination Product; Pipercillin Sodium - Tazobactam Sodium; Pipercillin Sodium, Tazobactam Sodium Drug Combination; Tazocel; Tazocillin; Tazocin; Zosyn
Pharm Action: Anti-Bacterial Agents
beta-Lactamase Inhibitors
Public MeSH Note: 2019; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION was indexed under PIPERACILLIN and PENICILLANIC ACID 1994-2018
History Note: 2019 (1994)
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/05/21

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0226081
Scope Note: An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS.
Terms: Piperacillin, Tazobactam Drug Combination Preferred Term
Term UI T000940924
Date03/07/2018
LexicalTag NON
ThesaurusID NLM (2015); Piperacillin - Tazobactam
Term UI T000940925
Date03/07/2018
LexicalTag NON
ThesaurusID NLM (2015); Piperacillin-Tazobactam Combination Product
Term UI T000940926
Date03/07/2018
LexicalTag NON
ThesaurusID NLM (1994)

Piperacillin, Tazobactam Drug Combination MeSH Descriptor Data 2024